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Abstract
Background: During primary infection of its human host, Herpes Simplex Virus Type-1 (HSV-1)
establishes latency in neurons where the viral genome is maintained in a circular form associated
with nucleosomes in a chromatin configration. During latency, most viral genes are silenced,
although the molecular mechanisms responsible for this are unclear. We hypothesized that
neuronal factors repress HSV-1 gene expression during latency. A search of the HSV-1 DNA
sequence for potential regulatory elements identified a Repressor Element-1/Neuronal Restrictive
Silencer Element (RE-1/NRSE) located between HSV-1 genes ICP22 and ICP4. We predicted that
the Repressor Element Silencing Transcription Factor/Neuronal Restrictive Silencer Factor (REST/
NRSF) regulates expression of ICP22 and ICP4.
Results:  Transient cotransfection indicated that REST/NRSF inhibited the activity of both
promoters. In contrast, cotransfection of a mutant form of REST/NRSF encoding only the DNA-
binding domain of the protein resulted in less inhibition. Stably transformed cell lines containing
episomal reporter plasmids with a chromatin structure showed that REST/NRSF specifically
inhibited the ICP4 promoter, but not the ICP22 promoter. REST/NRSF inhibition of the ICP4
promoter was reversed by histone deacetylase (HDAC) inhibitor Trichostatin A (TSA).
Additionally, chromatin immuno-precipitation (ChIP) assays indicated that the corepressor
CoREST was recruited to the proximity of ICP4 promoter and that acetylation of histone H4 was
reduced in the presence of REST/NRSF.
Conclusion: Since the ICP4 protein is a key transactivator of HSV-1 lytic cycle genes, these results
suggest that REST/NRSF may have an important role in the establishment and/or maintenance of
HSV-1 gene silencing during latency by targeting ICP4 expression.
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Background
Lytic infection by Herpes Simplex Virus Type-1 (HSV-1)
typically occurs in epithelial cells [1]. During these infec-
tions, HSV-1 expresses more than eighty genes in a
sequential regulatory cascade [2]. Immediate-early (IE or
α) gene products are the first group to be transcribed fol-
lowed by early (E or β) and late (L or γ) gene expressions
[3]. Expression of E and L genes depends on the availabil-
ity of IE proteins, thus demonstrating their importance in
the lytic cycle. During lytic infection, viral DNA is not
associated with nucleosomes. HSV-1, like other alphavi-
ruses, also establishes latent infections in sensory neurons
of the peripheral nervous system [4,5]. In contrast to lytic
infection, latency is distinguished by the absence of viral
polypeptides and a highly restricted pattern of transcrip-
tion [2,6]. Studies of HSV-1 latency in animal models
have indicated that the majority of viral DNA is main-
tained in a circular form and associated with nucleosomes
in a regularly spaced chromatin pattern [7]. However,
detailed studies of latent viral chromatin have been diffi-
cult to conduct and the role of chromatin in viral latency
remains to be defined.
We hypothesize that a repressive chromatin structure and
specific neuronal transcription factors contribute to tran-
scription inhibition during latency. We identified a
Restrictive Element-1/Neuronal Restrictive Silencer Ele-
ment (RE-1/NRSE) located between the promoters for the
Immediate-Early ICP4 and ICP22 genes. RE-1/NRSE is the
binding site of RE1-Silencing Transcription factor/Neuro-
nal Restrictive Silencer Factor (REST/NRSF) [8]. REST/
NRSF is a zinc finger transcription factor originally
defined as a silencer protein for the neuron-specific gene
SCG10 [9]. Recent studies revealed that REST/NRSF exhib-
its ubiquitous presence [10] and plays roles in neurogen-
esis, neural plasticity, tumor suppression, and cancer
progression through transcription regulation [11]. REST/
NRSF and its corepressor complex CoREST have not been
linked to HSV-1 biology until recent studies showing that
the HSV-1 IE protein ICP0 dissociates HDAC 1 and 2 from
the REST/CoREST complex [12]. However, the putative
role of REST/NRSF on HSV-1 transcription has not been
elucidated.
We investigated the effect of REST/NRSF on HSV-1 IE tran-
scription using an episomally replicating plasmid that
associates with nucleosomes in a standard chromatin con-
figuration in stably transfected cell lines [13]. Plasmids
containing the secreted alkaline phosphatase (SEAP)
reporter gene driven by either ICP4 or ICP22 promoter
were characterized in transient transfections and in stably
transformed cells. In transient transfections, REST/NRSF
repressed the activity of both the ICP22 and ICP4 promot-
ers. However, in stably transfected cells, REST/NRSF
exhibited significant inhibition of the ICP4 promoter but
only moderate reduction on ICP22 activity in chromatin
context. The histone deacetylase inhibitor trichostatin A
was sufficient to reverse the inhibition of ICP4 in stable
cells, indicating the role of histone deacetylation in REST/
NRSF mediated regulation in this system. ChIP assays
revealed that CoREST was recruited to the proximity of
HSV-1 RE-1/NRSE and that histone H4 acetylation was
reduced in the presence of REST/NRSF. These results dem-
onstrate the roles of REST/NRSF in the regulation of HSV-
1 IE transcription.
Results
A putative RE-1/NRSE was found within the promoter of 
HSV-1 ICP22
We identified a putative HSV-1 RE-1/NRSE having 76%
identity to the published consensus sequence [14] in the
intergenic region between the ICP4 and ICP22 coding
sequences (Fig. 1A). The location of various cis-acting ele-
ments was shown according to literature [15]. The HSV-1
RE-1 core sequence exhibited 100% identity to the con-
sensus RE-1/NRSE. This HSV-1 RE-1/NRSE is located
immediately downstream of the TATA box of the ICP22
promoter and 660 bp upstream of the ICP4 transcription
initiation site (Fig. 1B).
REST/NRSF repressed ICP22 and ICP4 promoter activity in 
transient co-transfection
The regulatory effect of REST/NRSF on the ICP22 pro-
moter was first measured by transient transfection assays.
We performed cotransfection of pICP22 (containing the
SEAP reporter gene under the control of the ICP22 pro-
moter) and pFLAG-REST into 293HEK cells at the molar
ratio of 1:1 or 1:2 (pICP22: pFLAG-REST). SEAP assays
were performed three days post-transfection according to
the manufacturer's protocols. The results indicated that
the REST/NRSF repressed the ICP22 promoter activity to
23% and 9% of control levels at the ratio of 1:1 and 1:2,
respectively (Fig. 2A). Similar co-transfections were done
with pCMVp73, which expresses a truncated form of
REST/NRSF containing only the protein's DNA binding
domain. The ICP22 promoter retained 70–80% of its
activity in the presence of REST/NRSF mutant p73 (Fig.
2A). Empty vector pREP-SEAP transfection was performed
and exhibited very low basal activity (data not shown).
The regulatory effect of REST/NRSF on the ICP4 promoter
was investigated by the same strategy. Cotransfection of
pICP4 and pFLAG-REST at the molar ratio of 1:1 or 1:2
(pICP4: pFLAG-REST) revealed that REST/NRSF inhibited
the ICP4 promoter activity to 2.5% and 1.2%, respec-
tively, (Fig. 2B). The mutant vector pCMVp73 exerted
only a weak repressive effect on the promoter (Fig. 2B).
These results indicated that REST/NRSF inhibited ICP22
and ICP4 promoter activity in transient transfections.
To further confirm the regulatory effect of REST/NRSF on
HSV-1 transcription, plasmid pSG28 and pH4-2 wereVirology Journal 2007, 4:56 http://www.virologyj.com/content/4/1/56
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cotransfected with pFLAG-REST or pCMVp73 to analyze
the effect of HSV-1 RE-1/NRSE on the gene regulation of
ICP4. It is noted that both pSG28 and pH4-2 contain the
complete open reading frame of ICP4, LAT, and ICP0. The
RT-PCR results indicated that REST/NRSF and mutant p73
exhibited no major effect on the ICP4 promoter of pSG28,
which does not have HSV-1 RE-1/NRSE (Fig. 2C). How-
ever, the ICP4 promoter of pH4-2 (containing HSV-1 RE-
1/NRSE) was significantly repressed by REST/NRSF but
not p73, which showed no inhibition at all (Lane 4, 5, and
6, Fig. 2C). The quantification analysis revealed that 62%
of ICP4 promoter activity in pH4-2 was repressed by
REST/NRSF, compared to 28% in pSG28 (Fig. 2D; black
bar, lane 4 and 5). In addition, REST/NRSF exhibited no
repression on LAT and ICP0 transcription in both plas-
REST/NRSF inhibits ICP22 and ICP4 promoter activity in  transient cotransfection Figure 2
REST/NRSF inhibits ICP22 and ICP4 promoter activ-
ity in transient cotransfection. A. Cotransfection of 
pICP22 with different amount of expression plasmids was 
performed followed by SEAP assay to analyze the regulatory 
effect of REST/NRSF on ICP22 promoter. 1. pICP22 and con-
trol plasmid. 2. pICP22 and pFLAG-REST (1:1). 3. pICP22 and 
pFLAG-REST (1:2). 4. pICP22 and pCMVp73 (1:1). 5. pICP22 
and pCMVp73 (1:2). The asterisk P values represent Stu-
dent's t tests in pairwise comparisons to the Lane 1 pICP22 + 
Control plasmid. The error bars represent standard devia-
tions. The data were calculated and graphed using Microsoft 
Excel. B. Cotransfection of pICP4 with different amount of 
expression plasmids was performed followed by SEAP assay 
to analyze the regulatory effect of REST/NRSF on ICP4 pro-
moter. 1. pICP4 and control plasmid. 2. pICP4 and pFLAG-
REST (1:1). 3. pICP4 and pFLAG-REST (1:2). 4. pICP4 and 
pCMVp73 (1:1). 5. pICP4 and pCMVp73 (1:2). The P values 
represent Student's t tests in pairwise comparisons to the 
Lane 1 pICP4 + Control plasmid. The error bars represent 
standard deviations. The data were calculated and graphed 
using Microsoft Excel. C. Plasmid pSG28 and pH4-2 were 
cotransfected with pFLAG-REST or pCMVp73 followed by 
RNA isolation and RT-PCR. 1. pSG28 and control plasmid 
(1:1). 2. pSG28 and pFLAG-REST (1:1). 3. pSG28 and 
pCMVp73 (1:1). 4. pH4-2 and control plasmid (1:1). 5. pH4-2 
and pFLAG-REST (1:1). 6. pH4-2 and pCMVp73 (1:1). D. The 
RT-PCR results were quantified by Kodak Gel-Logic 100 sys-
tem to measure the sum intensity of each band representing 
the regulatory effect of REST/NRSF on ICP4 transcription.
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HSV-1 genome and HSV-1 RE-1/NRSE sequence Figure 1
HSV-1 genome and HSV-1 RE-1/NRSE sequence. A. 
HSV-1 genome is composed of two covalently linked compo-
nents, designated as UL (Unique Long) or US (Unique Short). 
Each component contains unique sequences bracketed by 
inverted and terminal repeats (TRL and IRL). The ICP22 gene 
is present in US and one of the two ICP4 is located at the 
junction of US and IRS since the genes that are encoded 
within the repeat sequences are present twice in the viral 
genome. The HSV-1 RE-1/NRSE is mapped from 132082 to 
132103 according to the HSV-1 complete genome sequence 
accession number X14112. B. Putative HSV-1 RE-1/NRSE. 
The HSV-1 RE-1/NRSE sequence was identified to overlap 
ICP22 TATA box (Bold) compared to consensus sequence. 
The core sequence is underlined. The matching result indi-
cated that the homology is 76%. W: A or T; N: any nucle-
otide; S: G or C; Y: C or T; R: A or G.
HSV-1  RE-1  5’-TTATGTGCGCCGGAGAGACCC-3’
Consensus RE-1   5’-NNCAGCACCNCGGASAGNNNC-3’
              **  *  * ************ 
A.
B.
TRL                              UL                                      IRL  IRS              US            TRS
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mids (Fig. 2C and 2D, white and gray bars). These results
demonstrated that REST/NRSF required HSV-1 RE-1/
NRSE to exert its regulatory effect on ICP4 promoter.
Nucleosomes are associated with episomal plasmids in 
stable cells
To assess the effect of REST/NRSF on nucleosomal forma-
tion during transient transfection, we performed MNase
digestion on cells two days after the transfection of
reporter plasmids and expression vectors followed by
Southern blot hybridization using probes against the plas-
mid. The hybridization results revealed an irregular pat-
tern of nucleosomal ladder compared to the genomic
ladder and naked digestion control, suggesting that his-
tones were associated with the plasmid but not in a bona
fide nucleosomal structure (Fig. 3A). Expression of REST/
NRSF or p73 did not affect the nucleosomal configura-
tion.
To establish reporter plasmids that are assembled into
chromatin, we subjected cells transfected with the episo-
mally replicating pICP4 or pICP22 plasmids to hygromy-
cin B selection. The stable cells containing pICP22 or
pICP4 were established after 10 days of selection. To
examine the chromatin structure of the episomal plas-
mids, nuclei from parental and stable cells were again sub-
jected to different concentrations of MNase digestion
followed by Southern blot hybridization. Ethidium bro-
mide staining of the agarose gel revealed the nucleosome
protected ladder characteristic of genomic DNA (Fig. 3B,
Lane 1–3), indicating that the protocol of MNase diges-
tion was effective. Southern hybridization showed a plas-
mid-specific nucleosome protected ladder resembling the
genomic ladder (Fig. 3B, Lane 4 to 6). The nucleosomal
ladder of Southern hybridization is not an artifact since
the samples from parental cells exhibited no signal at all
(data not shown). These results demonstrated that the
plasmids are associated with nucleosomes in the stably
transfected cells. To test for integration of plasmids in
cells, total DNA purified from stable cells and plasmid
DNA was digested with NcoI, which cuts the plasmid
once, followed by Southern blot hybridization using vec-
tor probe. The results detected a single band with the size
of 11.2 kb, equivalent to the size of the original plasmid
(Fig. 3C). The results concluded that the plasmids
remained in an extra-chromosomal form since integrated
plasmid digestion would exhibit different sizes.
REST/NRSF repressed ICP4 but not ICP22 promoter 
activity in stable cell lines
To study the regulatory effect of REST/NRSF in a chroma-
tin context, we transfected stable cells harboring pICP22
(293HEK-pICP22) with pFLAG-REST or pCMVp73. The
cells were harvested for SEAP assays 72 hours after trans-
fection. These assays showed that the FLAG-REST and p73
proteins exerted only minor inhibitory effects on the
ICP22 promoter in 293HEK-pICP22 cells (Fig. 4A). Pro-
moter activity was mildly reduced to 63% and 78% of
control levels, respectively, by these proteins.
In contrast, we observed a significant inhibitory effect on
the ICP4 promoter by REST/NRSF in stable cells harbor-
ing pICP4 (293HEK-pICP4). SEAP assays showed that
ICP4 promoter activity was reduced to 21% of control lev-
els by REST/NRSF. On the other hand, ICP4 promoter
activity was essentially unchanged (94%) by the mutant
p73 (Fig. 4B). These results suggested that the REST/NRSF
Episomal plasmids remained in extra-chromosomal form and  associated with nucleosomes in stable cells Figure 3
Episomal plasmids remained in extra-chromosomal 
form and associated with nucleosomes in stable cells. 
A. Analysis of nucleosomal formation on transient trans-
fected reporter plasmid. Plasmid pICP4 was cotransfected 
with control vector (Lane 1, 2, 7, and 8), pFLAG-REST (Lane 
3, 4, 9, and 10), and pCMVp73 (Lane 5, 6, 11, and 12). Lane 
1–6: Ethidium bromide staining. Lane 7–12: plasmid-specific 
nucleosmal protected ladder detected by vector probe. Lane 
13 and 14: Naked plasmid digestion control. B. Analysis of 
nucleosomal formation on episomal plasmids. The nuclei 
from stable 293HEK-pICP22 were subjected to MNase diges-
tion followed by Southern blot hybridization. Lane 1–3: 
ethidium bromide staining of the genomic DNA nucleosomal 
protected ladder. Lane 4–6: episomal plasmid-specific nucle-
osmal protected ladder detected by vector probe. C. Exami-
nation of episomal status of plasmids in the stable cells 
harboring pICP4 by Southern hybridization. Lane 1. Total 
DNA purified from 1.28 × 106 stable cells; Lane 2: 10 pg plas-
mid; Lane 3: 0.1 ng plasmid DNA; 4: 1 ng plasmid DNA; 5: 10 
ng plasmid DNA.
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may cooperate with chromatin to inhibit ICP4 transcrip-
tion and the C-terminus of REST/NRSF played critical
roles in this directional repression.
The REST/NRSF-mediated ICP4 inhibition was released by 
HDAC inhibitor TSA
We predicted that the directional repression of ICP4 by
REST/NRSF is through histone deacetylation since the C-
terminal part of REST/NRSF was reported to recruit HDAC
[11,16]. To assess the role of histone deacetylation in this
system, 293HEK-pICP22 and 293HEK-pICP4 stable cell
lines were transfected with the control plasmid, pFLAG-
REST, or pCMVp73 with or without TSA. The HDAC
inhibitor TSA (100 nM, Sigma, MO) was added to the
media 24-hour after transfection. Cells were harvested for
SEAP assays 72-hour after transfection. In 293HEK-
pICP22 cells transfected with pFLAG-REST, very little
effect (1.2-fold induction) was observed in the presence of
TSA (Fig. 4A). However, in 293HEK-pICP4 cells trans-
fected with pFLAG-REST, TSA treatment increased ICP4
promoter activity 4.8-fold (Fig. 4B). We observed that the
ICP4 promoter activity was not affected by TSA in the
absence of REST/NRSF (Fig. 4B). To confirm that TSA did
not affect the expression of REST/NRSF, we isolated total
RNA from the transfected cells and performed RT-PCR
using primers against REST/NRSF and actin. The data
revealed that the transcriptions of REST/NRSF and p73
remained in the same pattern, indicating that the reactiva-
tion of ICP4 transcription by TSA is not due to the reduc-
tion of REST/NRSF expression (Fig. 4C). These results
indicated that histone acetylation has a critical role in
ICP4 gene expression in this system and that REST/NRSF
may induce histone deacetylation to repress transcription
of ICP4 in the context of chromatin.
REST/NRSF interacted with HSV-1 RE-1/NRSE
To confirm the expression of the fusion protein FLAG-
REST in the transfected 293HEK cells, we performed West-
ern Blotting using the anti-REST antibody. The results
indicated that the cells transfected with 1 µg of pFLAG-
REST showed significant increase of REST/NRSF expres-
sion compared to the control (Fig. 5A). The anti-REST
antibody (produced against amino acid residues 801–
1097 of human REST/NRSF) did not recognize mutant
p73 (amino acids 73–545).
To demonstrate the in vitro binding of REST/NRSF to the
HSV-1 RE-1/NRSE, we carried out EMSA using DIG-11-
ddUTP-labeled wild-type ds oligonucleotide (oligo) con-
taining HSV-1 RE-1/NRSE and oligo with core sequence
mutation. Extract isolated from cells transfected with
pFLAG-REST, pCMVp73, or control plasmids were used
for  in vitro interaction. The results revealed that both
REST/NRSF and mutant p73 yield strong, increased signal
of shifted bands while wild type oligo was used, demon-
strating that REST/NRSF and its DNA binding domain
bound to HSV-1 RE-1/NRSE in vitro (Fig. 5B, compare lane
1 to 2 and 4). The mutant oligo showed no band shifting,
indicating that core sequence of HSV-1 RE-1/NRSE is crit-
ical for the interaction (Fig. 5B, lane 3). The competition
analysis using unlabeled wild-type oligo abolished the
shifted bands, indicating that the interaction is specific
(Fig. 5B, lane 5 and 6).
REST/NRSF exhibited significant reduction on ICP4 pro- moter activity and the REST/NRSF-mediated repression was  reversed by HDAC inhibitor TSA Figure 4
REST/NRSF exhibited significant reduction on ICP4 
promoter activity and the REST/NRSF-mediated 
repression was reversed by HDAC inhibitor TSA. A. 
Stable 293HEK cells containing pICP22 (293HEK-pICP22) 
was transfected with control plasmid, pFLAG-REST, or 
pCMVp73 in the presence (white bar) or absence (black bar) 
of 100 nM TSA. 1. transfected with control plasmid. 2. trans-
fected with 1 µg of pFLAG-REST. 3. transfected with 1 µg of 
pCMVp73. The P values represent Student's t tests in pair-
wise comparisons to the control without TSA. B. Stable 
293HEK cells containing pICP4 (293HEK-pICP4) was trans-
fected with control plasmid, pFLAG-REST, or pCMVp73 in 
the presence (white bar) or absence (black bar) of 100 nM 
TSA. 1. transfected with control plasmid. 2. transfected with 
1 µg of pFLAG-REST. 3. transfected with 1 µg of pCMVp73. 
The P values represent Student's t tests in pairwise compari-
sons to the control without TSA. C. Effect of TSA on REST/
NRSF and p73 transcriptions in 293HEK-pICP4. M: 100 bp 
ladder. 1. Transfected with 1 µg control plasmid. 2. Trans-
fected with 1 µg pFLAG-REST. 3. Transfected with 1 µg 
pCMVp73. 4. Transfected with 1 µg control plasmid with 100 
nM TSA. 5. Transfected with 1 µg pFLAG-REST with 100 nM 
TSA. 6. Transfected with 1 µg pCMVp73 with 100 nM TSA. 
The cDNA from REST/NRSF and actin were marked by 
arrows.
A .         B .  
C.
      REST/NRSF or p73 cDNA 
      Actin cDNA 
      1            2          3           4           5           6         M 
          No TSA                      100 nM TSA 
   0      20     40    60    80   100   120%
      Normalized relative SEAP activity 
100
62.3
75.6
108.6
77.6
95.6
TSA
1
2
3
+ TSA
+ TSA
100
21.3,  p< 0.005 
91.3
127.6
96.6
105.6
1
2
3
 0     20   40   60    80   100  120%
      Normalized relative SEAP activity 
TSA
+ TSA
+ TSAVirology Journal 2007, 4:56 http://www.virologyj.com/content/4/1/56
Page 6 of 11
(page number not for citation purposes)
To investigate the in vivo binding of REST/NRSF to the
HSV-1 RE-1/NRSE, we performed ChIP using anti-FLAG®
M2 Affinity Gel. The results showed strong PCR signal
from pFLAG-REST IP sample compared to the control and
pCMVp73, indicating that FLAG-tagged REST/NRSF was
recruited to the minichromosomes (Fig. 5C, anti-FLAG
ChIP). The interaction of mutant p73 was not detected
due to the lack of FLAG-tag. In addition, only a very weak
signal was detected using primers against hygromycin B
resistance gene (Fig. 5C, HGB control), indicating that the
binding of REST/NRSF was specific to the promoter region
and the shearing of minichromosome was sufficient.
These results indicated that REST/NRSF and mutant p73
bound to the HSV-1 RE-1/NRSE.
REST/NRSF reduced the acetylation of histone H4 and 
CoREST was recruited to the proximity of the ICP4 
promoter
To analyze the participation of corepressor to HSV-1 RE-
1/NRSE, we performed ChIP using the anti-CoREST anti-
body. The results showed a much stronger signal from the
FLAG-REST transfected samples, indicating that CoREST is
recruited to HSV-1 RE-1/NRSE through REST/NRSF (Fig.
5C, anti-CoREST ChIP). We further investigated the his-
tone acetylation status by the same method using anti-
body against acetylated histone H4. The results revealed
that acetylation was reduced in the presence of REST/
NRSF compared to the control and p73 (Fig. 5C). These
results indicated that CoREST is recruited to the HSV-1 RE-
1/NRSE via the interaction of REST/NRSF in a chromatin
context and this interaction reduced the histone acetyla-
tion of histone H4 in the proximity of HSV-1 IE promot-
ers.
Discussion
In this study, we identified a RE-1/NRSE site in the HSV-1
genome between the ICP4 and ICP22 Immediate Early
promoters and showed that REST/NRSF exerted a chroma-
tin state-dependant repressive effect on the activity of
these promoters. In stably transformed cells, the plasmids
pICP4 and pICP22, respectively containing the HSV-1
ICP4 and ICP22 promoters and the SEAP reporter gene,
associated with nucleosomes in a regular chromatin array.
Thus the chromatin structure of these promoters should
resemble their structure in latently infected cells more
closely than in any other available model system. Trans-
fection of pFLAG-REST into these cells resulted in a sub-
stantial decrease in ICP4 promoter activity. This effect
required the effector domain of REST/NRSF since
pCMVp73, which contains only the DNA-binding
domain, had little effect on the ICP4 promoter. Repres-
sion of the ICP4 promoter by REST/NRSF was reversed by
Trichostatin A, suggesting that it was mediated, at least in
part, by histone deacetylation. This was confirmed by
ChIP analysis, which showed a significant reduction in
REST/NRSF recruited corepressor CoREST to HSV-1 RE-1/ NRSE and induced histone H4 deacetylation Figure 5
REST/NRSF recruited corepressor CoREST to HSV-
1 RE-1/NRSE and induced histone H4 deacetylation. 
A. Over-expression of REST/NRSF in 293HEK cells by trans-
fection of pFLAG-REST. Lane 1: 293HEK cells transfected 
with pICP4. Lane 2: 293HEK cells transfected with pICP4 and 
pFLAG-REST. Immunoblot was performed using anti-REST 
antibody. B. EMSA using transfected cell extract. Lane 1. 
Labeled HSV-1 RE-1 ds oligo incubated with extract isolated 
from cells transfected with control plasmid. Lane 2. Labeled 
HSV-1 RE-1 ds oligo incubated with extract isolated from 
cells transfected with pFLAG-REST. Lane 3: Labeled mutant 
oligo incubated with extract isolated from cells transfected 
with pFLAG-REST. Lane 4: Labeled HSV-1 RE-1 ds oligo incu-
bated with extract isolated from cells transfected with 
pCMVp73. Lane 5: Labeled wild-type ds oligo containing 10× 
unlabeled wild-type oligo incubated with extract isolated 
from cells transfected with pFLAG-REST. Lane 6: Labeled 
wild-type ds oligo containing 25× unlabeled wild-type oligo 
incubated with extract isolated from cells transfected with 
pFLAG-REST. Noted that endogenous REST/NRSF produced 
a shifted band (Lane 1). C. Analysis of REST/NRSF binding, 
histone H4 acetylation alteration, and CoREST recruitment 
by ChIP. 293HEK-pICP4 cell line was transfected with 
pFLAG-REST and subjected to ChIP assay. Samples prior to 
the immuno-precipitation are used for input control. The 
samples were amplified by PCR and subjected to 1.2% agar-
ose electrophoresis staining with ethidium bromide. 1. pICP4 
+ Control. 2. pICP4 + pFLAG-REST. 3. pICP4 + pCMVp73.
A .         B .  
C.
Anti-FLAG ChIP
Anti-acetyl H4 ChIP 
Anti-CoREST ChIP 
INPUT Control 
Anti-FLAG ChIP 
(HGB Control) 
REST/HSV-1 RE-1 
Oligonucleotide Complex 
Unbound 
Oligonucleotide 
           1    2    3   4    5    6
 pICP4  pICP4+REST 
    1        2 
REST/NRSF 
D-Tubulin
1         2        3 Virology Journal 2007, 4:56 http://www.virologyj.com/content/4/1/56
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the amount of acetylated histone H4 associated with the
ICP4 promoter in pFLAG-REST transfected cells. Consist-
ent with this, ChIP analysis also showed that CoREST,
which is able to recruit histone deacetylases, was also
associated with the ICP4 promoter in pFLAG-REST trans-
fected cells. This was further supported by the p73 data,
which indicated that the REST/NRSF mutant lacking effec-
tor region does not recruit CoREST to the promoter and
failed to deacetylate histone H4 at the promoter. In con-
trast to the ICP4 promoter, the ICP22 promoter was rela-
tively insensitive to repression by REST/NRSF. Since the
RE-1/NRSE is located approximately 660 bp upstream of
the ICP4 promoter but is adjacent to the ICP22 TATA box,
this may be due to directional or distance-dependent
effects, or it may indicate that REST/NRSF is able to exert
promoter-specific effects in a chromatin context.
In transiently transfected cells, the transfected plasmids
do not associate with nucleosomes in a regular chromatin
pattern and thus resemble viral DNA in lytically infected
cells. REST/NRSF repressed both the ICP4 and ICP22 pro-
moter in these cells. In these conditions, repression of
transcription from the ICP22 promoter might be due to
steric hindrance of the TATA box and/or the transcription
initiation site. However, repression of the ICP4 promoter
must be due to other repressive effects of REST/NRSF.
ICP22 and ICP4 have fundamentally different roles in
HSV-1 replication. ICP4 is essential for expression of E
and L genes [17]. ICP22 is not essential, but is required for
efficient replication [18] and transcription of HSV in cer-
tain cell types [19]. It is needed for maximal expression of
the γ1 and γ2 genes, probably due to the fact that ICP22
induces phosphorylation on the large subunit of cellular
RNA polymerase II [20]. The role of ICP22 in HSV-1
latency is not fully understood. No direct role for ICP22 in
establishment or maintenance of latent infection has been
demonstrated. However, given the transactivating effect of
ICP4, it may be more important for the virus to effectively
repress this promoter during these phases of latency, and
this may be mediated by REST/NRSF.
This study complements a recent report showing that
CoREST, a component of corepressor complex REST/CoR-
EST/HDACs, exhibits a sequence similarity at the amino
terminus to HSV-1 IE protein ICP0, and that the HDACs
may be dissociated from the corepressor complex by ICP0
in cells infected by wild-type viruses [12]. Thus, the
authors predicted that the REST/CoREST/HDACs complex
could cause HSV-1 gene silencing at low multiplicities of
infection (MOI). Our results revealed that CoREST is
recruited to HSV-1 RE-1/NRSE in the presence of REST/
NRSF, supporting the hypothesis that REST/CoREST com-
plexes participated in the regulatory effect on HSV-1 IE
genes. We predict this mechanism applies to HSV-1 latent
infection since REST/NRSF is present in neurons [10,21].
This is supported by studies showing that HSV mutants
lacking functional ICP0 exhibit poor reactivation effi-
ciency [22-24]. Furthermore, at low MOI, nonneuronal
cells infected with ICP0 deletion mutants produce about
100-fold less virus compared to cells infected with wild-
type virus. In these experiments, the lack of ICP0 may
have resulted in the failure to disrupt the inhibitory effect
of the REST/CoREST/HDACs complex on IE genes. Our
results showed that REST/NRSF inhibited ICP4 promoter
activity in a chromatin context, suggesting REST/NRSF
and repressive chromatin could maintain gene silencing
during the establishment of a transcriptionally silent state
and could provide a possible mechanism for long-term
persistence through histone modification. Histone modi-
fication is suggested to regulate transcription through a
mechanism of "histone code"[25]. Our ChIP analysis
indicated that at least one type of histone modification
(acetylation of histone H4) participated in the gene regu-
lation. It is not clear why REST/NRSF failed to repress the
ICP22 promoter activity in a chromatin context. However,
other nearby cis-acting elements may modulate the effects
of REST/NRSF. Sequence analysis indicates that the OriS,
located between the ICP4 and ICP22 promoters, may fold
into a stable hairpin [26]. A recent study suggested that
the OriS stem-loop structure encodes a microRNA that
may regulate HSV and host gene expression [27]. Our
hypothesis is that a chromatin insulator-like element par-
ticipated in the regulation of ICP22. Another recent study
identified a cluster of CTCF motifs, designated CTRS3, in
the intron of the ICP22 gene [28]. CTCF elements can
function as insulators shielding genes in one region of a
chromosome from the regulatory effects of another region
[29]. Two classes of insulators have been reported,
enhancer-blocking and boundary/barrier elements [28].
The former impedes the enhancer function and the latter
prevents the spreading of repressive heterochromatin into
the transcriptionally active area. Based on our results, we
predict that CTRS3 and/or OriS act as a boundary/barrier
element to prevent the repressive chromatin from spread-
ing to the ICP22 promoter and thus aborted the inhibi-
tory effect of REST/NRSF on ICP22 in the presence of
nucleosomes. Further studies using neuronal models and
promoter deletion are required to elucidate the complex
regulatory mechanisms.
Conclusion
In summary, we have provided the first direct evidence
indicating that REST/NRSF can regulate HSV-1 IE gene
expression. We propose that during the establishment and
maintenance of latent infection, REST/NRSF binds to the
HSV-1 RE-1/NRSE in a chromatin context and recruits
CoREST/HDAC complexes. As a result, the repressor com-
plexes inhibit the ICP4 transcription and produce long-
term repression via histone deacetylation, and possiblyVirology Journal 2007, 4:56 http://www.virologyj.com/content/4/1/56
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chromatin methylation (Fig. 6). More experiments are
underway to investigate the role of REST/NRSF on HSV-1
gene regulation using neuronal cells and animal models.
Methods
Construction of plasmids and PCR amplification
The construction of episomal vector pICP4 and pICP22
were essentially described previously [30]. REST/NRSF
expression vectors pFLAG-REST and pCMVp73 are gifts
from Dr. Gail Mandel (SUNY, Stony Brook, NY). Plasmid
pFLAG-REST expresses fusion protein REST/NRSF with a
FLAG tag and pCMVp73 is a mutant REST/NRSF encoding
485 amino acids of the DNA-binding domain [31].
The plasmid pH4-2, based on pUC19, contains the Hind
III restriction fragment (non-prototype structure) cover-
ing the entire long and short internal repeats. Plasmid
pSG28, based on pUC18, contains EcoR I fragment cover-
ing HSV-1 sequence from 106785 to 131534. Both plas-
mids contain open reading frame of ICP4, LAT, and ICP0.
However, pH4-2 contains HSV-1 RE-1/NRSE and ICP22
promoter but pSG28 does not. Plasmid pGL3-basic
(Promega, Madison, WI) was used as control for transfec-
tion.
Cell culture, transfection and selection for stable cell lines
The 293HEK cell is a human embryonic kidney cell line
and was purchased from the American Type Culture Col-
lection (ATCC) and maintained in DMEM medium sup-
plemented with 10% fetal bovine serum (FBS). For
transfection, cultures of cells were prepared for transfec-
tion by plating 5 × 105 cells in 60 mm culture dishes. After
overnight incubation, the cells were transfected with 5 µg
plasmid DNA complexed with 20 µl Superfect reagent
(Qiagen, Valencia, CA) according to the procedures rec-
ommended by the manufacturer. To obtain stably trans-
formed cell lines, the transfected cells were trypsinized 72
hours after transfection and replated in T25 flasks in
medium containing 200 µg/ml of hygromycin B (Invitro-
gen, CA).
Western Blot analysis
293HEK cells (2 × 10 6) were transfected with pFLAG-
REST or pCMVp73. For the preparation of cell extracts, the
monolayers were washed with ice-cold phosphate-buff-
ered saline (PBS), and the cells were lysed by adding 5 ml
of cell extract buffer (25 mM Tris-HCl, 50 mM β-glycerol
phosphate, 1 mM EGTA, 0.5 mM EDTA, 5% glycerol, 1%
Triton X-100, 0.1 mM Benzamidine, 0.5 M Na3VaO4, 0.5
M phenylmethylsulfonyl fluoride, and protease inhibitors
cocktail tablets from Roche). Protein concentration was
determined by the Bradford protein assay (Bio-Rad, Her-
cules, CA). Proteins were subjected to 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis and
transfered onto nitrocellulose membranes. The blots were
blocked using PBS with 5% (wt/vol) non-fat dry milk and
washed in PBS. Anti-REST rabbit polyclonal antibody
(Upstate Biotechnology, Lake Placid, NY) was used at a
dilution of 1:1,000. After overnight incubation primary
antibody was washed off in 1× PBST (1× PBS + 0.05%
Tween 20) followed by the addition of secondary anti-
body (anti rabbit IgG-horseradish peroxidase conjugate,
Amersham Bioscience, Piscataway, NJ) at a dilution of
1:2,000 in PBST for one hour at room temperature. The
membranes were washed as before and visualized using
enhanced-chemiluminescence reagents (Pierce) according
to the manufacturer's protocol. Anti-α-Tubulin mouse
antibody (Calbiochem, Cat#: CP06) was added at a dilu-
tion of 1:10,000 in PBST, and the secondary antibody
(goat anti mouse IgG – horseradish peroxidase conjugate,
PerkinElmer Life Sciences, Wellesley, MA) was added at a
dilution of 1:5,000 in PBST for one hour at room temper-
ature.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed using a DIG Gel shift Kit 2nd gener-
ation (Roche applied science, Indianapolis, IN) essen-
tially described in the manufacturer's protocol. Briefly,
single-stranded oligonucleotides (oligo) 5'-GGC CTT TAT
GTG CGC CGG AGA GAC CCG CCC-3' and its comple-
mentary oligo were synthesized (Invitrogen, San Diego,
CA) and annealed to make double-stranded (ds) REST
oligo. The core sequence is underlined. The oligo 5'-GGC
CTT TAT GTG CGC TTT TGA GAC CCG CCC-3' and its
complementary oligo were synthesized and annealed as
mutant control. The ds oligos were terminally-labeled
with non-radioactive DIG-11-ddUTP by terminal trans-
ferase and incubated with the protein extracts isolated
from parental cells or cells transfected with REST/NRSF or
mutant p73 expression vectors for 15 min at room tem-
perature. In addition, 10× or 25× of wild-type unlabeled
oligo were added to the labeled oligo for competition
Proposed model of HSV-1 ICP4 and ICP22 regulation by  REST/NRSF Figure 6
Proposed model of HSV-1 ICP4 and ICP22 regulation 
by REST/NRSF. REST/NRSF interacts with HSV-1 RE-1 in 
chromatin and represses ICP4 by recruiting CoREST and 
HDAC to induce hypoacetylation around the ICP4 pro-
moter.
ICP22
Transcription 
REST/CoREST 
Co-repressor 
complex
ICP4
Transcription 
RE-1/NRSE 
Histone H4 
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analysis. The samples were electrophoresed on a 6% DNA
Retardation Gel (Invitrogen, CA) at 80 V for 1 h followed
by alkaline transfer to positive-charged nylon membrane
and chemiluminescence detection.
Nuclei isolation and micrococcal nuclease (MNase) 
digestion
To partially digest cellular chromatin with MNase, a T75
flask of cells was harvested by trypsinization. The cells
were washed once with Dulbecco's PBS, and then washed
twice with 5 ml ice-cold tris buffered saline (TBS) (10 mM
tris, pH 7.5, 150 mM NaCl, 5 mM MgCl2). The cells were
then washed with 2 ml of ice-cold CB buffer (10 mM Tris,
pH 8.0, 10 mM NaCl, 5 mM MgCl2 supplemented with 1
mM dithiothreitol on the day of use), and then washed
again with 1 ml ice-cold CB. The cells were pelleted once
more, and lysed by resuspending them in 0.5 ml ice-cold
CB plus 0.5% Triton X-100. Nuclei were pelleted by cen-
trifugation at 2000 × g for 5 min. The nuclei were resus-
pended in 50 µl ice-cold CB and 9 µl aliquots of nuclei
were added to 0.5 ml microfuge tubes containing 1 µl
MNase freshly diluted in MNase digestion buffer (20 mM
PIPES, pH 7.0, 1 mM MgCl2, 10 mM NaCl, 250 mM
sucrose, supplemented with 1 mM CaCl2, and 5 mM 2-
mercaptoethanol). A stock solution of MNase (Fermentas
Cat#: EN0181) was purchased and stored at -20°C. Nuclei
were digested with different concentrations of MNase at
room temperature for 20 min. After the MN reaction, the
nuclei were digested by addition of 225 µl proteinase K
solution (20 µg proteinase K/ml in 0.5% SDS, 10 mM tris,
pH 8.0, 5 mM EDTA) followed by overnight incubation at
37°C. DNA was precipated at -20°C for 1 h after addition
of 25 µl 3.0 M sodium acetate, pH 5.2, and 500 µl propa-
nol. After centrifugation, DNA was washed with 70% eth-
anol prior to electrophoresis.
Southern blot hybridization
The DNA was subjected to gel electrophoresis (1.2% aga-
rose gel, 6 hours at 40 volts). After electrophoresis, the gel
was treated twice with denaturing solution (0.4 N NaOH
solution) for 15 min at room temperature. The DNA was
transferred for 6 h from the gel to a positively charged
nylon membrane using an alkaline transfer protocol.
Hybridization was performed overnight at 42°C. To make
a whole plasmid probe, linear pREP-SEAP DNA was
labeled using Prime-a-Gene® Labeling System (Cat. No:
TB049) from Promega (Madison, WI) based on the ran-
dom-primed method.
Chemiluminescent SEAP assays
Promoter activity was analyzed by measuring SEAP
reporter gene activity using GreatEscape kit according to
the manufacturer's protocol (BD Biosciences). Transiently
or stably transformed cells were plated in 60-mm plates at
5 × 105 cells/plate. After 2 days when an evenly distributed
monolayer had formed, the medium was replaced with
fresh DMEM medium and the flasks were incubated over-
night. Fifteen µl of culture medium was collected and
mixed with 45 µl of dilution buffer. The samples were
incubated at 65°C for 30 min, after which 60 µl of assay
buffer was added to the cooled samples. The reaction mix
then was incubated at room temperature for 5 min fol-
lowed by addition of 60 µl of 1.25 mM CSPD substrate
according to the manufacturer's protocol. The chemilumi-
nescent signal was measured at 420 nm by 20/20n Lumi-
nometer (Turner Biosystems, Sunnyvale, CA) after 10 min
incubation. Each construct was tested using a minimum
of three replicates and the data were collected and normal-
ized as SEAP units relative to the controls.
Reverse transcriptase PCR (RT-PCR)
For RT-PCR, total RNA from cultured cells was isolated by
Trizol reagent (Invitrogen). RT-PCRs were performed
using Superscript One-Step RT-PCR (Invitrogen) with 0.5
µg of total RNA and two primer sets per reaction tube: one
set for the actin as a control and another for the REST/
NRSF. The RT-PCR primers were designed to bind in dif-
ferent exons to avoid unintentional amplification of
potential genomic DNA contamination. Their sequences
are as follows: Actin: 5'-ATT CCT ATG TGG GCG ACG AG-
3' and 5'-TGG ATA GCA ACG TAC ATG GC-3'; REST/
NRSF: 5'-TGT ATT TGA GGC ATC AGG TGC TC-3' and 5'-
GTG TGG TGT TTC AGG TGT GCT G-3'; ICP4: 5'-CGA
CAC GGA TCC ACG ACC C-3' and 5'-GAT CCC CCT CCC
GCG CTT CGT CCG-3'; LAT: 5' CGG CGA CAT CCT CCC
CCT AAG C 3' and 5' GAC AGA CGA ACG AAA CGT TCC
G 3'; ICP0: 5'-TTC GGT CTC CGC CTG AGA GT-3' and 5'-
GAC CCT CCA GCC GCA TAC GA-3'. The reverse tran-
scription/PCR reaction was carried out at 45°C for 20 min
followed by 25 cycles of 94°C for 30 s, 55°C for 30 s, and
68°C for 30 s. The RT-PCR products were analyzed by 2%
agarose gel electrophoresis. The Kodak Gel-Logic 100 sys-
tem was utilized for quantification.
Chromatin Immunoprecipitation (ChIP) assays
The protocol was essentially described in Hsia and Shi
[32] with modification according to the manufacturer's
manual. Briefly, the cell monolayer was treated with 1%
formaldehyde solution for 10 min at room temperature.
The monolayer was then scraped into 15 ml tubes and
subjected to the nuclei isolation protocol described previ-
ously. The samples were fragmented by MNase digestion
(3.75 units/µl on ice for 1 h). The reaction was stopped by
EDTA at the final concentration of 50 mM. The nuclei was
pelleted and incubated with 400 µl of SDS lysis buffer
(1% SDS, 10 mM EDTA, and 50 mM Tris-HCl {pH 8.1})
containing proteinase inhibitor (Complete Mini, Roche)
on ice for 10 min. The lysed samples were spun for 10 min
at 13,000 g with a refrigerated Eppendorf microfuge at
4°C, and the supernatant was diluted 10-fold with dilu-Virology Journal 2007, 4:56 http://www.virologyj.com/content/4/1/56
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tion buffer (25 ml; 0.01% SDS, 1.1% Triton X-100, 1.2
mM EDTA, 16.7 mM Tris-HCl {pH 8.1}, and 167 mM
NaCl) containing protease inhibitor as described above.
Immunoprecipitation was then performed with a ChIP
assay kit essentially as described by the manufacturer with
an antibody against acetylated H4 (Cat#: 17-229, Upstate
Biotechnology, Lake Placid, N.Y.). This is a polyclonal
antibody generated by using peptide corresponding to
amino acids 2–19 of Tetrahymena histone H4 [AGGAcKG-
GAcKGM GAcKVGAAcKRHSC], acetylated on lysines 5, 8,
12 and 16. For immunoprecipitation of FLAG fusion pro-
tein, EZview™ Red ANTI-FLAG® M2 Affinity Gel (Sigma-
Aldrich Biotechnology, St. Louis, MO, Cat#: F2426) was
utilized. Anti-CoREST, against human CoREST corre-
sponding to residue 109–293, was purchased from
Upstate Biotechnology (Cat#: 07-455). To analyze the
DNA immuno-precipitated by the antibody or affinity gel,
PCR amplification was performed on the precipitated
DNA with primers (5'-TGG GGT GGG CGG GTC TTT C-3'
and 5'-ACG AAC GAC GGG AGC GGC TG-3') against
HSV-1 RE-1/NRSE. The primer sequences against hygro-
mycin B gene (HGB) are 5'-TTG TTG GAG CCG AAA TCC
G-3' and 5'-CAA ACT GTG ATG GAC GAC ACC G-3'.
For each reaction, a 50-µl, 25-cycle PCR was carried out in
the presence of 10 pmol of the primers. Each cycle con-
sisted of 1 min at 94°C, 40 s at 50°C, and 1 min at 72°C.
Each experiment was done at least twice with similar
results. The ChIP PCR products were analyzed by 2% aga-
rose gel electrophoresis.
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